Location: Palo Alto, CA
CIK: 0001892134 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $1.506B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MIRM | MIRUM PHARMACEUTICALS INC | 6,470,392 | $204M | 13.6% | $23.31 | +17.5% | COM | 604749101 |
| — | HILLEVAX INC | 9,781,472 | $132M | 8.7% | $11.23 | — | COM | 43157M102 |
| KRYS | KRYSTAL BIOTECH INC | 988,460 | $115M | 7.6% | $64.17 | +90.1% | COM | 501147102 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 12,131,705 | $112M | 7.5% | $10.46 | +3.5% | ORDINARY SHARES | N62509109 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 10,109,279 | $105M | 7.0% | $13.68 | +0.2% | COM | 71722W107 |
| BBIO | BRIDGEBIO PHARMA INC | 2,725,949 | $71.88M | 4.8% | $17.20 | +65.0% | COM | 10806X102 |
| PCVX | VAXCYTE INC | 1,164,405 | $59.36M | 3.9% | $21.85 | +125.8% | COM | 92243G108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,371,304 | $54.36M | 3.6% | $19.67 | +13.9% | COM | 76243J105 |
| — | VERONA PHARMA PLC | 3,014,349 | $49.13M | 3.3% | $14.56 | — | SPONSORED ADS | 925050106 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,589,931 | $47.28M | 3.1% | $20.28 | +1.6% | COM | 22663K107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 8,684,232 | $46.11M | 3.1% | $17.08 | -50.2% | COM | 03969K108 |
| — | ALPINE IMMUNE SCIENCES INC | 2,985,757 | $34.19M | 2.3% | $8.97 | — | COM | 02083G100 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,787,527 | $31.76M | 2.1% | $17.82 | -0.7% | COM | 87650L103 |
| KALV | KALVISTA PHARMACEUTICALS INC | 3,238,859 | $31.19M | 2.1% | $9.73 | +5.0% | COM | 483497103 |
| IRON | DISC MEDICINE INC | 655,000 | $30.77M | 2.0% | $35.48 | +41.0% | COM | 254604101 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,403,013 | $28.75M | 1.9% | $18.18 | 0.0% | COM | 77313F106 |
| RVMD | REVOLUTION MEDICINES INC | 997,455 | $27.61M | 1.8% | $25.35 | +17.0% | COM | 76155X100 |
| APLS | APELLIS PHARMACEUTICALS INC | 614,043 | $23.36M | 1.6% | $43.93 | 0.0% | COM | 03753U106 |
| ANTX | AN2 THERAPEUTICS INC | 1,388,889 | $22.33M | 1.5% | $11.32 | 0.0% | COM | 037326105 |
| — | MERUS N V | 746,479 | $17.6M | 1.2% | $25.59 | — | COM | N5749R100 |
| — | AEROVATE THERAPEUTICS INC | 1,204,867 | $16.35M | 1.1% | $17.37 | — | COM | 008064107 |
| ANAB | ANAPTYSBIO INC | 899,700 | $16.16M | 1.1% | $30.26 | -36.9% | COM | 032724106 |
| SVRA | SAVARA INC | 4,000,000 | $15.12M | 1.0% | $3.56 | 0.0% | COM | 805111101 |
| TRVI | TREVI THERAPEUTICS INC | 6,881,090 | $15M | 1.0% | $2.88 | -21.4% | COM | 89532M101 |
| COGT | COGENT BIOSCIENCES INC | 1,501,383 | $14.64M | 1.0% | $7.19 | +65.0% | COM | 19240Q201 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,050,483 | $14.35M | 1.0% | $19.61 | -14.1% | COM | 29337E102 |
| TYRA | TYRA BIOSCIENCES INC | 1,028,013 | $14.16M | 0.9% | $11.75 | +26.2% | COM | 90240B106 |
| SLNO | SOLENO THERAPEUTICS INC | 464,937 | $13.72M | 0.9% | $6.05 | 0.0% | COM | 834203309 |
| ACAD | ACADIA PHARMACEUTICALS INC | 630,897 | $13.15M | 0.9% | $16.19 | +67.7% | COM | 004225108 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,142,855 | $12.96M | 0.9% | $5.68 | +44.3% | COM | 68622P109 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 3,746,857 | $8.73M | 0.6% | $4.17 | — | SPON ADS | 05280R100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 600,000 | $8.712M | 0.6% | $17.68 | +7.0% | COM | 87164F105 |
| SLN | SILENCE THERAPEUTICS PLC | 881,173 | $8.662M | 0.6% | $19.00 | — | ADS | 82686Q101 |
| — | CEREVEL THERAPEUTICS HLDNG I | 393,000 | $8.579M | 0.6% | $28.54 | — | COM | 15678U128 |
| APGE | APOGEE THERAPEUTICS INC | 400,000 | $8.52M | 0.6% | $22.03 | 0.0% | COM | 03770N101 |
| MGNX | MACROGENICS INC | 1,803,204 | $8.403M | 0.6% | $6.03 | -17.5% | COM | 556099109 |
| AGIO | AGIOS PHARMACEUTICALS INC | 292,002 | $7.227M | 0.5% | $26.45 | 0.0% | COM | 00847X104 |
| REPL | REPLIMUNE GROUP INC | 386,762 | $6.617M | 0.4% | $18.89 | +4.0% | COM | 76029N106 |
| NTLA | INTELLIA THERAPEUTICS INC | 203,684 | $6.44M | 0.4% | $84.72 | -54.2% | COM | 45826J105 |
| PRTA | PROTHENA CORP PLC | 127,900 | $6.171M | 0.4% | $58.56 | +1.5% | SHS | G72800108 |
| — | THESEUS PHARMACEUTICALS INC | 2,248,194 | $6.048M | 0.4% | $6.45 | — | COM | 88369M101 |
| ARVN | ARVINAS INC | 285,331 | $5.604M | 0.4% | $67.21 | -63.5% | COM | 04335A105 |
| — | BLUEBIRD BIO INC | 1,709,907 | $5.198M | 0.3% | $5.85 | — | COM | 09609G100 |
| EWTX | EDGEWISE THERAPEUTICS INC | 849,022 | $4.865M | 0.3% | $8.91 | -23.7% | COM | 28036F105 |
| — | DECIPHERA PHARMACEUTICALS IN | 370,000 | $4.706M | 0.3% | $14.08 | — | COM | 24344T101 |
| — | SUTRO BIOPHARMA INC | 780,000 | $2.707M | 0.2% | $8.22 | — | COM | 869367102 |
| — | GRITSTONE BIO INC | 1,430,878 | $2.461M | 0.2% | $4.12 | — | COM | 39868T105 |
| ACRS | ACLARIS THERAPEUTICS INC | 264,377 | $1.811M | 0.1% | $13.64 | -37.4% | COM | 00461U105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 600,000 | $1.566M | 0.1% | $17.68 | +7.0% | Put | 87164F105 |
| ADCT | ADC THERAPEUTICS SA | 1,647,030 | $1.477M | 0.1% | $3.69 | -63.9% | SHS | H0036K147 |
| — | PASSAGE BIO INC | 1,758,219 | $1.157M | 0.1% | $3.10 | — | COM | 702712100 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 500,333 | $951K | 0.1% | $0.87 | — | *W EXP 11/22/202 | N62509117 |